| Without disability | With disability | |
|---|---|---|
| N | 98.00 | 42.00 |
| Disability (%) | 0 | 53.14±23.7 |
| SLICC | 0.75±0.98 | 1.8±1.10 |
| Age at SLE diagnosis | 34.6±14.8 | 30.7±10.4 |
| SLE evolution (years) | 13.9±10.7 | 20.7±8.10 |
| Nervous system damage (%) | 12.24 | 28.57 |
| Musculoskeletal damage (%) | 88.78 | 90.48 |
| Mucocutaneus damage (%) | 72.45 | 76.19 |
| Serositis (%) | 7.14 | 14.29 |
| Cardiovascular damage (%) | 13.27 | 19.05 |
| Cytopenia (%) | 42.86 | 47.62 |
| Renal damage (%) | 13.27 | 19.05 |
| Raynaud's (%) | 29.59 | 47.62 |
| Antiphospholipid synd. (%) | 7.14 | 11.90 |
| Sjögren synd. (%) | 16.33 | 23.81 |
| Vasculitis (%) | 1.02 | 4.76 |